Comparative Pharmacology
Head-to-head clinical analysis: HEPARIN SODIUM 5 000 UNITS IN SODIUM CHLORIDE 0 45 versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HEPARIN SODIUM 5 000 UNITS IN SODIUM CHLORIDE 0 45 versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Heparin binds to antithrombin III, causing a conformational change that accelerates the inhibition of thrombin and activated factor X (factor Xa). It also catalyzes the inhibition of other coagulation factors including XIIa, XIa, IXa, and VIIa.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
IV: Initial bolus 80 units/kg, then continuous infusion at 18 units/kg/hr, adjusted to aPTT 1.5-2.5 times control. Subcutaneous: 5,000 units every 8-12 hours.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
Mean terminal elimination half-life is 1-2 hours at therapeutic doses, but it is dose-dependent and can increase with higher doses. Clinical context: Anticoagulant effect persists longer than plasma levels due to irreversible binding to antithrombin III.
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Primarily renal, with some hepatic metabolism and reticuloendothelial system clearance. Unchanged heparin is excreted in urine via glomerular filtration; high molecular weight fractions are cleared more rapidly than low molecular weight fractions.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte